Patent · US Active

VHR protein tyrosine phosphatase inhibitors, compositions and methods of use

US8188080B2 · kind B2 · utility

13Cited by
1References
35Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 17, 2008
Grant dateMay 29, 2012
Priority date—
Expiry dateNov 2, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are Vaccinia H1-related (VHR) protein tyrosine phosphatase (PTP) inhibitors that provide a method for treating cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.